Meenakshi Bewtra1, Lisa M Kaiser, Tom TenHave, James D Lewis. 1. Division of Gastroenterology and Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. meenakshi.bewtra@uphs.upenn.edu
Abstract
BACKGROUND: Evidence regarding all-cause and cause-specific mortality in inflammatory bowel disease (IBD) is conflicting, and debate exists over appropriate study design to examine these important outcomes. We conducted a comprehensive meta-analysis of all-cause and cause-specific mortality in both Crohn's disease (CD) and ulcerative colitis (UC), and additionally examined various effects of study design on this outcome. METHODS: A systematic search of PubMed and EMBASE was conducted to identify studies examining mortality rates relative to the general population. Pooled summary standardized mortality ratios (SMR) were calculated using random effect models. RESULTS: Overall, 35 original articles fulfilled the inclusion and exclusion criteria, reporting all-cause mortality SMRs varying from 0.44 to 7.14 for UC and 0.71 to 3.20 for CD. The all-cause mortality summary SMR for inception cohort and population cohort UC studies was 1.19 (95% confidence interval, 1.06-1.35). The all-cause mortality summary SMR for inception cohort and population cohort CD studies was 1.38 (95% confidence interval, 1.23-1.55). Mortality from colorectal cancer, pulmonary disease, and nonalcoholic liver disease was increased, whereas mortality from cardiovascular disease was decreased. CONCLUSIONS: Patients with UC and CD have higher rates of death from all causes, colorectal-cancer, pulmonary disease, and nonalcoholic liver disease.
BACKGROUND: Evidence regarding all-cause and cause-specific mortality in inflammatory bowel disease (IBD) is conflicting, and debate exists over appropriate study design to examine these important outcomes. We conducted a comprehensive meta-analysis of all-cause and cause-specific mortality in both Crohn's disease (CD) and ulcerative colitis (UC), and additionally examined various effects of study design on this outcome. METHODS: A systematic search of PubMed and EMBASE was conducted to identify studies examining mortality rates relative to the general population. Pooled summary standardized mortality ratios (SMR) were calculated using random effect models. RESULTS: Overall, 35 original articles fulfilled the inclusion and exclusion criteria, reporting all-cause mortality SMRs varying from 0.44 to 7.14 for UC and 0.71 to 3.20 for CD. The all-cause mortality summary SMR for inception cohort and population cohort UC studies was 1.19 (95% confidence interval, 1.06-1.35). The all-cause mortality summary SMR for inception cohort and population cohort CD studies was 1.38 (95% confidence interval, 1.23-1.55). Mortality from colorectal cancer, pulmonary disease, and nonalcoholic liver disease was increased, whereas mortality from cardiovascular disease was decreased. CONCLUSIONS:Patients with UC and CD have higher rates of death from all causes, colorectal-cancer, pulmonary disease, and nonalcoholic liver disease.
Authors: M Cottone; A Magliocco; M Rosselli; F Pinzone; L Oliva; A Orlando; M R Aiala; C Cipolla; L Pagliaro Journal: Scand J Gastroenterol Date: 1996-04 Impact factor: 2.423
Authors: Frank L Wolters; Maurice G Russel; Jildou Sijbrandij; Leo J Schouten; Selwyn Odes; Lene Riis; Pia Munkholm; Ebbe Langholz; Paolo Bodini; Colm O'Morain; Kostas Katsanos; Epameinondas Tsianos; Severine Vermeire; Gilbert Van Zeijl; Charles Limonard; Ole Hoie; Morten Vatn; Bjørn Moum; Reinhold W Stockbrügger Journal: Scand J Gastroenterol Suppl Date: 2006
Authors: C Saro Gismera; M Lacort Fernández; G Argüelles Fernández; J L Antón Magarzo; A Suárez González; R García López; C A Navascués; G Díaz Alvarez; A González Bernal Journal: Rev Esp Enferm Dig Date: 1999-03 Impact factor: 2.086
Authors: T Jess; E V Loftus; W S Harmsen; A R Zinsmeister; W J Tremaine; L J Melton; P Munkholm; W J Sandborn Journal: Gut Date: 2006-01-19 Impact factor: 23.059
Authors: Thierry Delaunoit; Paul J Limburg; Richard M Goldberg; James F Lymp; Edward V Loftus Journal: Clin Gastroenterol Hepatol Date: 2006-03 Impact factor: 11.382
Authors: Fanni Rencz; Márta Péntek; Martin Bortlik; Edyta Zagorowicz; Tibor Hlavaty; Andrzej Śliwczyński; Mihai M Diculescu; Limas Kupcinskas; Krisztina B Gecse; László Gulácsi; Peter L Lakatos Journal: World J Gastroenterol Date: 2015-02-14 Impact factor: 5.742
Authors: Meenakshi Bewtra; Vikram Kilambi; Angelyn O Fairchild; Corey A Siegel; James D Lewis; F Reed Johnson Journal: Inflamm Bowel Dis Date: 2014-01 Impact factor: 5.325